Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
Key themes:
Downgrading Financials. Given the Sectorâs relative deterioration, we are downgrading Financials to market weight. Pockets of strength...